Last reviewed · How we verify
ibuprofen Formulation 2
At a glance
| Generic name | ibuprofen Formulation 2 |
|---|---|
| Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (PHASE2)
- Canadian National PDA Treatment Study
- Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III) (PHASE1, PHASE2)
- Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus (PHASE2)
- Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial (PHASE2)
- A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets (PHASE1)
- Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache (PHASE3)
- Ibuprofen Bioavailability Trial With Oral Single Dose Administration. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |